| Original language | English |
|---|---|
| Pages (from-to) | 2995-2996 |
| Number of pages | 2 |
| Journal | Leukemia and Lymphoma |
| Volume | 56 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 3 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: Tyrosine kinase inhibitors, donor lymphocyte infusions or both?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver